F
Fernando G. Cosio
Researcher at Mayo Clinic
Publications - 241
Citations - 21501
Fernando G. Cosio is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 76, co-authored 240 publications receiving 19977 citations. Previous affiliations of Fernando G. Cosio include University of Minnesota & University of Rochester.
Papers
More filters
Journal ArticleDOI
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Kim Solez,Robert B. Colvin,Lorraine C. Racusen,Mark Haas,Banu Sis,Michael Mengel,Philip F. Halloran,William M. Baldwin,G. Banfi,A. B. Collins,Fernando G. Cosio,D. S. R. David,Cinthia B. Drachenberg,Gunilla Einecke,Agnes B. Fogo,Ian W. Gibson,Denis Glotz,Samy S. Iskandar,Edward S. Kraus,Evelyne Lerut,Roslyn B. Mannon,Michael J. Mihatsch,Brian J. Nankivell,Volker Nickeleit,John C. Papadimitriou,Parmjeet Randhawa,Heinz Regele,Karine Renaudin,Ian S.D. Roberts,Daniel Serón,Rex Neal Smith,Marialuisa Valente +31 more
TL;DR: Emerging research data led to the establishment of collaborative working groups addressing issues like isolated ‘v’ lesion and incorporation of omics‐technologies, paving the way for future combination of graft biopsy and molecular parameters within the Banff process.
Journal ArticleDOI
Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease
Andrew D. Rule,Timothy S. Larson,Erik J. Bergstralh,Jeff Slezak,Steven J. Jacobsen,Fernando G. Cosio +5 more
TL;DR: This cross-sectional study compared GFR estimated by the MDRD equation with GFR measured by iothalamate clearance in 320 patients with chronic kidney disease and 580 healthy kidney donor candidates, and developed a new GFR prediction equation based on both healthy persons and patients with Chronic kidney disease.
Journal ArticleDOI
Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups
Banu Sis,Michael Mengel,Mark Haas,Robert B. Colvin,Philip F. Halloran,Lorraine C. Racusen,Kim Solez,William M. Baldwin,Erika Bracamonte,V. Broecker,Fernando G. Cosio,Anthony J. Demetris,Cinthia B. Drachenberg,Gunilla Einecke,James M. Gloor,Denis Glotz,Edward S. Kraus,Christophe Legendre,Helen Liapis,Roslyn B. Mannon,Brian J. Nankivell,Volker Nickeleit,John C. Papadimitriou,Parmjeet Randhawa,Heinz Regele,Karine Renaudin,E. R. Rodriguez,Daniel Serón,Surya V. Seshan,Manikkam Suthanthiran,Barbara A. Wasowska,Andrea A. Zachary,A. Zeevi +32 more
TL;DR: The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v‐lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance.
Journal ArticleDOI
Identifying Specific Causes of Kidney Allograft Loss
Ziad M. El-Zoghby,Mark D. Stegall,Donna J. Lager,Walter K. Kremers,Hatem Amer,James M. Gloor,Fernando G. Cosio +6 more
TL;DR: Targets for investigation and intervention are identified that may result in improved kidney transplantation outcomes and alloinmunity remains the most common mechanism leading to failure.
Journal ArticleDOI
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.
Mark D. Stegall,Tayyab S. Diwan,Suresh Raghavaiah,Lynn D. Cornell,Justin M. Burns,Justin M. Burns,Patrick G. Dean,Fernando G. Cosio,Manish J. Gandhi,Walter K. Kremers,James M. Gloor +10 more
TL;DR: Inhibition of terminal complement activation with eculizumab decreases the incidence of early AMR in sensitized renal transplant recipients (ClincalTrials.gov number NCT006707).